TB-500 + BPC-157: When to Stack and When to Cycle Separately
A practical decision framework for the most common peptide stack in recovery-focused protocols. Goals, timelines, and how to track stacks cleanly.
At a glance
- What it is
- BPC-157 + TB-500 recovery stack
- Route
- SC injection
- Frequency
- BPC daily, TB-500 1-2× weekly
- Typical cycle
- 4-8 weeks
- First effects
- 2-6 weeks
Best for
TB-500 (thymosin beta-4 fragment) and BPC-157 are the two most-discussed peptides in recovery circles. They have different mechanisms, different half-lives, and a lot of overlap in claimed effects. The question every self-experimenter eventually asks: stack them, or cycle separately?
What each one is supposed to do
- BPC-157: short half-life, daily dosing, soft-tissue and gut-focused effects in research models.
- TB-500: long half-life (days, not hours), typically dosed 1–2× weekly, broader systemic effects in research models.
The mechanisms differ enough that, in theory, they target different parts of the healing process.
The stack argument
Most self-experimenters report stacking the two when:
- The injury is significant (post-surgery, full tendon rupture, multiple sites)
- They want results faster and accept losing experimental clarity
- They have stable protocols and just want the combined effect
The counter-argument: if you run them together and recover, you cannot say which one did the work. For long-term self-experimentation, that matters.
The cycle-separately argument
If your goal is to learn how you respond to each peptide, run them sequentially:
- Cycle A (4 weeks): BPC-157 daily. Track everything.
- Wash-out (2–4 weeks): no peptides. Continue tracking.
- Cycle B (4 weeks): TB-500 1–2× weekly. Track everything.
After both cycles you have N=2 datasets in the same body. That is dramatically more useful than one combined log.
Decision framework
Ask three questions:
- Is this an acute, time-sensitive injury? If yes, stack. Speed matters more than experimental cleanliness.
- Have you ever run either peptide before? If no, cycle separately. You need to know each one's effect on you.
- Are you tracking? If no, do not stack. The data complexity outpaces your ability to interpret it.
How to track a stack
If you do stack, do not try to log them as one item. Treat them as two protocols running in parallel:
- Separate dose logs for each
- A single shared journal for daily metrics (sleep, pain, recovery score)
- A weekly photo or objective measurement (range of motion, pain-free reps)
Peptid AI's stack manager keeps each peptide's schedule independent while sharing your outcome journal so trends are easy to read.
Timing within a stack
Common patterns:
- BPC-157 daily, AM
- TB-500 once weekly, same day each week (often Mondays)
There is no published evidence that the timing of TB-500 within the week matters much given its long half-life. Pick a day, stick to it, log it.
Bottom line
Stacking is a shortcut: faster perceived results, lower experimental clarity. Cycling separately is an investment: slower perceived results, much better personal data. Pick based on whether you are solving a problem in front of you or building knowledge for the next decade.
Peptid AI is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.
Atlas entry
TB-500 + BPC-157 stack — half-life, route and cautions
Subcutaneous